Biogen Soars 9.02% on Groundbreaking Alzheimer’s Drug Advancements: A New Era...
Boston, MA – October 1, 2025 – Biogen Inc. (NASDAQ: BIIB) saw...
A One‑Time Brain Gene Therapy Just Slowed Huntington’s by 75%—Is This...
Key facts (quick read)What happened this week: Early clinical trial data for AMT‑130, an AAV5 gene therapy delivered by neurosurgery into the striatum, reported a 75% slowing...
Doctors report major breakthrough in Huntington's disease
Doctors achieve first successful Huntington's disease treatment using gene therapy that slows disease progression by 75% in groundbreaking clinical trial.
Source link
Breast Cancer Advancements in Prevention, Diagnosis, and Treatment, and What is...
It is October, and it’s Breast Cancer Awareness month. On MidPoint on October 1st, we interviewed Dr. Tara O’Connor, a medical oncologist at Moffitt...
Sylvester Researchers to Showcase Breakthrough Findings at ASTRO 2025
Groundbreaking Radiation Oncology Research from Sylvester Comprehensive Cancer Center to Take Center Stage at ASTRO 2025
The Sylvester Comprehensive Cancer Center, in collaboration with the...
Breakthrough fat treatment shows promise to restore aging vision
Age-related vision loss has long seemed inevitable, but new research suggests it may not be a one-way street. In experiments with older mice, scientists...
Advances in Prostate Cancer Treatment: Targeted Radioactive Therapy,
Physicians and researchers at the UCLA Health Jonsson Comprehensive Cancer Center are poised to deliver groundbreaking insights into radiation oncology at the 2025 American...
Huntington’s disease breakthrough ‘is like winning the lottery 10 times over’
Gemma BottingBut even having children was something that took some navigating. They decided they wanted to screen out the gene that causes the disease....
Science news this week: A breakthrough cure for Huntington’s disease and...
This week's science news has been dominated by medical marvels, with the announcement of a breakthrough gene therapy that has treated Huntington's disease for...